Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review

Sigfrid L. et al, (2020), BMC Medicine, 18

Hydroxychloroquine for COVID-19: Balancing contrasting claims

Horby PW. and Emberson JR., (2020), European Journal of Internal Medicine

Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.

Wang W. et al, (2020), The Journal of infectious diseases

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

Clift AK. et al, (2020), BMJ, m3731 - m3731

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

RECOVERY Collaborative Group None. et al, (2020), The New England journal of medicine

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2020), Lancet (London, England)

Deaths Associated with Pneumonic Plague, 1946-2017.

Salam AP. et al, (2020), Emerging infectious diseases, 26, 2432 - 2434

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Knight SR. et al, (2020), BMJ, m3339 - m3339

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

Swann OV. et al, (2020), BMJ, m3249 - m3249

Human plague: An old scourge that needs new answers.

Vallès X. et al, (2020), PLoS neglected tropical diseases, 14

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.

Rojek AM. et al, (2020), BMC medicine, 18

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.

Randremanana RV. et al, (2020), Trials, 21

Core Outcomes Set for Trials in People With Coronavirus Disease 2019.

Tong A. et al, (2020), Critical care medicine

International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019.

Evangelidis N. et al, (2020), Critical care medicine

Early clinical characteristics of Covid-19: scoping review

Manoharan L. et al, (2020)

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Knight SR. et al, (2020)

A minimal common outcome measure set for COVID-19 clinical research

Marshall JC. et al, (2020), The Lancet Infectious Diseases, 20, e192 - e197

ISARIC Clinical Data Report 4 October 2020

Pritchard M. et al, (2020)

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.

RECOVERY Collaborative Group None. et al, (2020), The New England journal of medicine

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?